We use own cookies and thirds to offer you better service More information Accept
Back to News

Mar. 2018

NuPharm Group launches its new website www.nupharm.com


NuPharm introduces its full focus on the treatment of central nervous system disorders (CNS) through its new website and corporate identity

NuPharm Group's new website www.nupharm.com emerges with the aim of being the corporate showcase of the group deriving from the union of the Spanish companies InkeLaboratories Lesvi and Qualigen, the German company neuraxpharm and the Italian company FB Health.

 

The website highlights all of the information concerning its drugs for CNS: branded medicines, generic medicines and nutraceutical medicines. Also, the website shows the dimensions and potential of the Group, its decided backing of R+D, its sales force and production capabilities.

Along with the website, the Group also introduces its corporate image with a logo that demonstrates its focus on CNS disorders, by using the image of a neurone.

What is also important with regards the company’s visual identity is the image of a lighthouse that symbolises NuPharm’s aim to be a reference for leading the way on the treating these pathologies, whilst remembering the need that patients have of being able to rely on the best alternatives to deal with their disorders.

To learn more about the NuPharm Group, visit www.nupharm.com